CVS adds Wegovy to its top formularies and bolsters its Weight Management program, aiming to expand access while cutting costs.

GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain FDA approval by 2026.

Lifestyle therapy may not be enough to improve outcomes for patients with HF and obesity, but careful risk evaluation and ...

In what she calls the "wild west" of obesity medicines, Missouri-based Amy Spencer is a pioneer.

China’s nascent weight loss drug market is poised for rapid growth ... The Chinese company ran large clinical trials suggesting that in local patients, it appeared just as effective as Lilly’s ...

With more than 600 million Chinese adults projected to be overweight by 2050, the emergence of a viable local alternative to Novo and Lilly’s blockbuster GLP-1 treatments could make weight loss drugs ...

A setback today seems much worse than it is. Don't let it bring you down, and try to ensure that others around you are also dealing with it appropriately. Despair is never the answer, especially not ...

Your passion for travel is fully engaged right now, so make plans or hit the road on a whim. You're certain to meet cool people and have amazing experiences if you can free yourself from your routines ...